Possible Interactions between Dietary Antioxidants and Chemotherapy

ONCOLOGY

Volumn 13, Issue 7, 1999, Pages 1003-1008

  Labriola, Dan ^a   Livingston, Robert ^b  

^a Northwest Natural Health Specialty Care Clinic   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ALPHA TOCOPHEROL; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATALASE; DOXORUBICIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SUPEROXIDE DISMUTASE; UBIDECARENONE;

ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER CHEMOTHERAPY; DIETARY INTAKE; DRUG CYTOTOXICITY; HUMAN; MEDICAL DECISION MAKING; ORAL DRUG ADMINISTRATION; PREDICTION; REVIEW;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 0032805202     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Eisenberg DM, Kessler RC, Foster C, et al: Unconventional medicine in the United States: Prevalence, costs, and patterns of use. N Engl J Med 328(4):246-252, 1993.
2. National Nutritional Foods Association: Antioxidants Show Promise in Colorectal Cancer. vol 11, p 6. Newport Beach, California, National Nutritional Foods Association, 1997.
3. Lockwood K, Moesgaard S, Folkers K: Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun 199(3):1504-1508, 1994.
4. Dimirpence E, Balaguer P, Trousse F, et al: Antiestrogenic effects of all-trans-retinoic acid and 1,25 dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54:1458-1464, 1994.
5. van den Brandt PA, Goldbohm A, van't veer P, et al: Toenail selenium levels and the risk of breast cancer. Am J Epidemiol 140(1):14020-14026, 1994.
6. Hunter DJ, Morris JS, Stampfer MJ, et al: A prospective study of selenium status and breast cancer risk. JAMA 264:1128-1131, 1990.
7. Shinozawa S, Kawasaki H, Gomita Y: Effect of biological membrane stabilizing drugs (coenzyme Q10, dextran sulfate and reduced glutathione) on Adriamycin (doxorubicin) induced toxicity and microsomal lipid peroxidation in mice. Gan To Kagaku Ryoho 23(1):93-98, 1996.
8. Beyer RE: An analysis of the role of coenxyme Q in free radical generation and as an antioxidant. Biochem Cell Biol 70(6):390-403, 1992.
9. Shinozawa S, Gomita Y, Araki Y: Tissue concentration of doxorubicin in mice pretreated with alpha-tocopherol or coenzyme Q10. Acta Med Okayama 45(3):195-199, 1991.
10. WAF/CIPI via C/EBP(beta). Nat Med (11):1233-1241, 1997.
11. Chabner BA, Collins JM: Cancer Chemotherapy: Principles and Practice, pp 276-297, 314-333. Philadelphia, JB Lippincott, 1990.
12. Black DJ, Livingston RB: Antineoplastic drugs in 1990: A review (part I). Drugs 39:489-501, 1990.
13. Black DJ, Livingston RB: Antineoplastic drugs in 1990: A review (part II). Drugs 39:652-673, 1990.
14. Henner WD, Peters WP, Eden JP: Pharmacokinetics and immediate effects of high-dose carmustine in man. Cancer Treat Rep 70:877-880, 1986.
15. Connors TA: Mechanisms of clinical drug resistance. Biochem Pharm 23(suppl 2):89-100, 1974.
16. Kirkwood JM, Lotze MT, Yasko JM: Current Cancer Therapeutics, pp 1-6, 37-40. Philadelphia, Churchill Livingstone, 1996.
17. Macdonald JS, Haller DG, Mayer RJ: Manual of Oncologic Therapeutics, pp 80-135. Philadelphia, JB Lippincott, 1995.
18. Enger SM, Longnecker MP, Shikany JM, et al: Questionnaire assessment of intake of specific carotenoids. Cancer Epidemiol Biomarkers Prev 4(3):201-205, 1995.
19. Jarvinen R: Carotenoids, retinoids, tocopherols, and tocotrienols in the diet - the Finnish mobile clinic health examination survey. Int J Vitam Nutr Res 65(1):24-30, 1995.
20. Taylor PR, Wang GQ, Sanford MD, et al: Effect of nutrition intervention on intermediate end points in esophageal and gastric carcinogenesis. Am J Clin Nutr 62(suppl):1420S-1423S, 1995.
21. Frommel TO, Sohrab M, Doria M, et al: Effect of beta-carotene supplementation on indices of colonic cell proliferation. J Natl Cancer Inst 87(23):1781-1787, 1995.
22. Garewal HS: Antioxidants and Disease Prevention, pp 19-26. New York, CRC Press, 1997.
23. Erhola M, Kellokumpu-Lehtinen P, Metsa-Ketela T, et al: Effect of anthracycline-based chemotherapy on total plasma antioxidant capacity in small-cell lung cancer patients. Free Radic Biol Med 21(3):383-390, 1996.
24. Koracheva S, Ribarov SR: Lipid peroxidation in lung of rats stresses by immobilization effects of vitamin E supplementation. Lung 173(4):255-263, 1995.
25. Ihara Y, Mon A, Hayabara T, et al: Free radicals, lipid peroxides, and antioxidants in blood of patients with myotonic dystrophy. J Neurol 242(3):119-122, 1995.
26. Abbey M, Noakes M, Nestel PJ: Dietary supplementation with orange and carrot juice in cigarette smokers lowers oxidation products in copper-oxidized low-density lipoproteins. J Am Diet Assoc 95(6):671-675, 1995.
27. Bast A, Haenen GR, Doelman CJ: Oxidants and antioxidants: State of the art. Am J Med 91(3c):2S-13S, 1991.
28. Hadidi AH, Coulter CE, Idle JR: Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patients. Cancer Res 48:5167-5171, 1988.
29. Culvert AH, Newell DR, Gore HE: Future directions with carboplatin: Can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin? Semin Oncol 19(suppl 2):155-163, 1992.
30. Corden BJ, Fine RL, Ozols RF, et al: Clinical pharmacology of high-dose cisplatin. Cancer Chemother Pharmacol 14:38-41, 1985.
31. Dechant KL, Brogden RN, Pillington T, et al: Ifosfamide/mesna: A review of antineoplastic activity, pharmacokinetic properties, and therapeutic efficacy in cancer. Drugs 42:428-467, 1991.